22
HOSPI TALS
HOSPITALS/SYSTEMS DIGEST 2013
SANOFI / MANAGED CARE DIGEST SERIES
®
/ WHERE INFORMATION BECOMES INTELLIGENCE.
™
• For all 12 drug class profiled, the number of
retail prescriptions dispensed per 1,000 patients
fell between midyear 2010 and midyear 2012,
with osteoporosis prescriptions dropping 39.2%.
• Over these three years, retail prescription
spending increased for several drug classes,
with cholesterol drugs accounting for the
highest spending, at $77.19 per patient per year.
Data source: IMS Health © 2013
Key Takeaway
The falling rate of retail prescription use could be linked to the Affordable Care Act provision that
allows young adults to remain on their parents’ health insurance plan until age 26. The provision,
enacted in September 2010, increased the overall pool of insured Americans by more than
3 million young adults
4
—most of whom might be less likely to fill prescriptions.
Out-of-Pocket Costs Fall for Most Retail Prescription Categories in 2012
• Across most of the drug classes tracked, out-of-
pocket costs per retail prescription fell between
midyear 2011 and midyear 2012. Such costs
for oncology drugs dropped a notable 13.9%.
• Over this period, out-of-pocket costs per
prescription increased fractionally for four
drug categories: arthritis, depression, diabetes
and asthma (which was highest, at $29.31).
PHARMACY
$28.15
$29.31
$28.30
$28.28 $30.94
$26.64
$23.18
$22.72
$22.05
$22.30
$23.18
$22.04
$18.44
$18.17
$17.58
$17.80
$14.71
$15.03
$12.12
$11.99
2011
2012
Diabetes Cholesterol
Osteoporosis
$0
$8
$16
$24
$32
Average Out-of-Pocket Costs
Oncology
Asthma Antiplatelets
Allergies Depression Arthritis Hypertension
Out-of-Pocket Costs Per retail Prescription
1,3
Total Number of retail RXs per 1,000 Patients and Total retail RX Spending per Patient Per YEar
1
Total Rxs per 1,000 Patients
Total Rx Spending per Patient per Year
2
Drug Class
2010
2011
2012
2010
2011
2012
Allergies
337.0
309.7
233.2
$18.59
$17.27
$12.87
Antiplatelets
269.6
253.7
251.3
30.34
32.22
34.79
Arthritis
411.7
402.5
406.0
22.36
21.95
22.33
Asthma
593.8
554.8
549.8
66.78
66.93
74.21
Cholesterol
1,027.5
976.5
961.4
73.34
73.79
77.19
Depression
1,032.5
998.2
1,019.0
54.75
51.17
48.17
Diabetes
675.8
665.8
665.0
61.79
65.44
71.50
Gastrointestinal
81.5
72.4
70.6
8.22
8.47
9.14
Hypertension
2,795.4
2,640.6
2,616.7
79.30
73.52
69.99
Oncology
63.0
59.6
60.5
15.92
12.45
11.05
Osteoporosis
147.6
114.6
89.7
10.83
8.91
7.33
Sleep Disorder
255.6
245.8
243.4
12.06
10.59
9.29
1
Data are as of midyear 2012 and represent the number/percentages of prescriptions dispensed, by drug class, to all patients.
2
The total full price the pharmacy charges the patient for the product, regardless of copayment situation.
3
Out-of-pocket cost is the actual amount paid by the patient for the individual prescription. This cost mainly includes copayments, but can also
include tax, deductibles and cost differentials where applicable.
4
U.S. Department of Health and Human Services. (2012). New Health Care Law Helps More Than 3 Million Young Adults Get and Keep Health
Coverage. Retrieved from
http://www.hhs.gov/news/press/2012pres/06/20120619b.html
Note: Pharmacy utilization, spending and out-of-pocket costs data come from IMS Health’s Vector One
®
: Payer (VOPA) Platform.
Retail Prescription Use per 1,000 Patients Declines
CHRONIC DISEASE
I...,12,13,14,15,16,17,18,19,20,21 23,24,25,26,27,28,29,30,31,32,...IV